Multiplexed immunoassays measure multiple analytes simultaneously, saving time and sample volume.
However, this technology comes with challenges including cross-reactivity, standardization, signal interference, sample matrix effects, and data analysis. At Discovery Life Sciences (Discovery), we leverage the latest immunoassay technologies coupled with our quality-driven protocols and optimized workflows to overcome these challenges.
Our latest technical note on “Sensitive Detection and Quantification of Low Abundant Cytokines Using Multiplex Immunoassay Services” highlights how Discovery’s proteomic experts established a highly sensitive cytokine assay using the Invitrogen ProcartaPlexTM panel on the Luminex xMAP® INTELLIFLEX system to reliably detect the smallest changes in protein expression in complex plasma samples.
